Self-Management App for Patients With Left-Ventricular Assist Devices
Completed · Not applicable
Conditions studied: Heart Failure
In brief
The purpose of this study is to evaluate the use of VAD Care App in an out-patient mechanical circulatory support program. The specific aim for this pilot study is to obtain preliminary efficacy data of the VAD Care App as a self-management tool for patients with long-term LVADs. A randomized control trial will be employed to establish preliminary estimates of the effects of the App on the following outcomes: self-efficacy and adherence to the LVAD care regimen; LVAD-related complications and health care utilization \[e.g., hospital re-admission\]; overall health status and quality of life. The duration of the study is 6 months.
Key facts
- Study ID
- NCT03049748
- Run by
- University of Michigan
- People needed
- 40
- Starts
- 2017-01-30
- Expected to finish
- 2019-07-01
- Last updated by the study team
- 2020-06-16
Who can join
Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients: Recipient of second or third generation LVAD; minimum of 6th grade education; can read and understand the English Language; and to be discharged from the hospital within a week of enrollment
- Caregivers: Designated as primary caregiver at home and a minimum of 6th grade education
You may not qualify if…
- Patients and caregivers: Illiterate, blind, inability to use a mobile phone, cannot hear alarms, and/or evidence of cognitive impairment documented in the medical record or an abnormal results of a Mini Mental State Exam
Where it is running
- Barnes-Jewish Hospital/Washington University — St Louis, Missouri, United States
- Bryan Heart — Lincoln, Nebraska, United States
- New York Presbyterian Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.